Detalhe da pesquisa
1.
Reproducible and Characterized Method for Ponatinib Encapsulation into Biomimetic Lipid Nanoparticles as a Platform for Multi-Tyrosine Kinase-Targeted Therapy.
ACS Appl Bio Mater
; 3(10): 6737-6745, 2020 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35019338